Peripheral blood kinetics following total body irradiation and allogeneic hematopoietic stem cell transplantation: Timing matters

被引:2
作者
Dejonckheere, Cas S. [1 ]
Boehner, Alexander M. C. [2 ]
Schmitz, Eva [3 ]
Holderried, Tobias A. W. [4 ]
Schmeel, Leonard C. [1 ]
Brossart, Peter [4 ]
Giordano, Frank A. [5 ]
Koeksal, Mumtaz A. [1 ]
机构
[1] Univ Hosp Bonn, Dept Radiat Oncol, Venusberg Campus 1, D-53127 Bonn, Germany
[2] Univ Hosp Bonn, Inst Mol Med & Expt Immunol, Bonn, Germany
[3] Univ Hosp Bonn, Dept Neurol, Bonn, Germany
[4] Univ Hosp Bonn, Dept Oncol Hematol Immunooncol & Rheumatol, Bonn, Germany
[5] Univ Med Ctr Mannheim, Dept Radiat Oncol, Mannheim, Germany
来源
CANCER MEDICINE | 2023年 / 12卷 / 06期
关键词
acute lymphoblastic leukemia; acute myeloid leukemia; allogeneic hematopoietic stem cell transplantation; total body irradiation; ACUTE LYMPHOBLASTIC-LEUKEMIA; BONE-MARROW-TRANSPLANTATION; CONDITIONING REGIMENS; RANDOMIZED-TRIAL; GRAFT FAILURE; SURVIVAL; BUSULFAN; DISEASE;
D O I
10.1002/cam4.5452
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Total body irradiation (TBI) remains an important component in many conditioning regimens before allogeneic hematopoietic stem cell transplantation (allo-HSCT). Because of its frequent toxicity, patient selection is crucial, making it of interest to identify factors improving engraftment. In this retrospective single center analysis, the characteristics of 48 adult such patients were studied. Mean overall survival (OS) was 22.2 months after allo-HSCT. Interestingly, people with an interval >= 3 days between TBI completion and allo-HSCT showed improved OS, when compared to a shorter interval (p = 0.10). Peripheral blood kinetics after successful engraftment also differed, with a longer interval resulting in a higher platelet count and lower leukocyte and neutrophil (p < 0.05) count. These data suggest that the exact timing of TBI before allo-HSCT might directly impact a patient's survival and could help single out those at higher risk of graft failure who might benefit from an altered conditioning regimen.
引用
收藏
页码:7170 / 7174
页数:5
相关论文
共 22 条
  • [1] Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complete remission
    Blaise, D
    Maraninchi, D
    Michallet, M
    Reiffers, J
    Jouet, JP
    Milpied, N
    Devergie, A
    Attal, M
    Sotto, JJ
    Kuentz, M
    Ifrah, N
    Duriac, C
    Bordigoni, P
    Gratecos, N
    Guilhot, F
    Guyotat, D
    Gluckman, E
    Vernant, JP
    [J]. BLOOD, 2001, 97 (11) : 3669 - 3671
  • [2] Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia:: A Pediatric Blood and Marrow Transplant Consortium study
    Bunin, N
    Aplenc, R
    Kamani, N
    Shaw, K
    Cnaan, A
    Simms, S
    [J]. BONE MARROW TRANSPLANTATION, 2003, 32 (06) : 543 - 548
  • [3] Risk factors and outcome of graft failure after HLA matched and mismatched unrelated donor hematopoietic stem cell transplantation: a study on behalf of SFGM-TC and SFHI
    Cluzeau, T.
    Lambert, J.
    Raus, N.
    Dessaux, K.
    Absi, L.
    Delbos, F.
    Devys, A.
    De Matteis, M.
    Dubois, V.
    Filloux, M.
    Fort, M.
    Hau, F.
    Jollet, I.
    Labalette, M.
    Masson, D.
    Mercier, B.
    Pedron, B.
    Perrier, P.
    Picard, C.
    Quainon, F.
    Ramounau-Pigot, A.
    Renac, V.
    Van Endert, P.
    Charron, D.
    de la Tour, R. Peffault
    Taupin, J. L.
    Loiseau, P.
    [J]. BONE MARROW TRANSPLANTATION, 2016, 51 (05) : 687 - 691
  • [4] Treatment Complications and Long-term Outcomes of Total Body Irradiation in Patients with Acute Lymphoblastic Leukemia: A Single Institute Experience
    De Felice, Francesca
    Grapulin, Lavinia
    Musio, Daniela
    Pomponi, Jenny
    Di Felice, Cinzia
    Iori, Anna Paola
    Bertaina, Alice
    Tombolini, Vincenzo
    [J]. ANTICANCER RESEARCH, 2016, 36 (09) : 4859 - 4864
  • [5] Survival, disease-free survival and adverse effects of conditioning for allogeneic bone marrow transplantation with busulfan/cyclophosphamide vs total body irradiation:: a meta-analysis
    Hartman, AR
    Williams, S
    Dillon, JJ
    [J]. BONE MARROW TRANSPLANTATION, 1998, 22 (05) : 439 - 443
  • [6] TRENDS IN UTILIZATION OF TOTAL BODY IRRADIATION (TBI) PRIOR TO HEMATOPOIETIC CELL TRANSPLANTATION (HCT) WORLDWIDE
    Hong, S.
    Barker, C.
    Klein, J. P.
    Shaw, P.
    Bredeson, C.
    Angelina, A.
    Rowlings, P.
    Cahn, J. -Y.
    Dabaja, Kharfan-M
    Aljurf, M.
    Szer, J.
    Wood, W. A.
    Ahmed, I
    Gomez-Almaguer, D.
    Atsuta, Y.
    Pasquini, M. C.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S336 - S337
  • [7] Current and future approaches to treat graft failure after allogeneic hematopoietic stem cell transplantation
    Locatelli, Franco
    Lucarelli, Barbarella
    Merli, Pietro
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (01) : 23 - 36
  • [8] Pulmonary Toxicity after Total Body Irradiation-An Underrated Complication? Estimation of Risk via Normal Tissue Complication Probability Calculations and Correlation with Clinical Data
    Oertel, Michael
    Kittel, Christopher
    Martel, Jonas
    Mikesch, Jan-Henrik
    Glashoerster, Marco
    Stelljes, Matthias
    Eich, Hans Theodor
    [J]. CANCERS, 2021, 13 (12)
  • [9] Graft failure in the modern era of allogeneic hematopoietic SCT
    Olsson, R.
    Remberger, M.
    Schaffer, M.
    Berggren, D. M.
    Svahn, B-M
    Mattsson, J.
    Ringden, O.
    [J]. BONE MARROW TRANSPLANTATION, 2013, 48 (04) : 537 - 543
  • [10] Graft failure after allogeneic hematopoietic stem cell transplantation
    Ozdemir, Zehra Narli
    Bozdag, Sinem Civriz
    [J]. TRANSFUSION AND APHERESIS SCIENCE, 2018, 57 (02) : 163 - 167